The estimated Net Worth of Lisa Kelly is at least $10.8 Million dollars as of 15 November 2012. Lisa Kelly owns over 2,388 units of Vertex Pharmaceuticals stock worth over $7,223,644 and over the last 17 years Lisa sold VRTX stock worth over $3,623,064.
Lisa has made over 19 trades of the Vertex Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently Lisa sold 2,388 units of VRTX stock worth $98,338 on 15 November 2012.
The largest trade Lisa's ever made was selling 37,726 units of Vertex Pharmaceuticals stock on 7 May 2012 worth over $2,090,020. On average, Lisa trades about 3,035 units every 16 days since 2007. As of 15 November 2012 Lisa still owns at least 15,216 units of Vertex Pharmaceuticals stock.
You can see the complete history of Lisa Kelly stock trades at the bottom of the page.
Lisa's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: